Founded with a vision to revolutionize at-home and point-of-care testing, Burst Diagnostics develops innovative rapid antigen diagnostic solutions. Their core mission is to provide accessible, fully automated laboratory analysis in a portable format, empowering individuals to conduct reliable health tests from the comfort of their homes. The company's primary products include diagnostic devices for sexually transmitted infections (STIs), respiratory viruses, and strep throat, focusing on delivering quick and accurate results.
Burst Diagnostics has garnered attention for its cutting-edge technology and impactful contributions to the healthcare industry. The company boasts a team of experts in medical diagnostics and technology innovation. Notable investors have recognized the potential of Burst Diagnostics' platform, contributing to its growth and development. The startup's achievements include significant advancements in rapid diagnostic testing, positioning it as a key player in the market for at-home medical solutions.